References
- Fiellin, D. A., Pantalon, M. V., Chawarski, M. C., Moore, B. A., Sullivan, L. E., O'Connor, P. G., & Schottenfeld, R. S. (2006). Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence. The New England Journal of Medicine, 355, 365–374.
- Hay, G., Gannon, M., McKeganey, N., Hutchinson, S., & Goldberg, D. (2005). Estimating the national and local prevalence of problem drug misuse in Scotland: Executive report. Glasgow: Centre for Drug Misuse Research, University of Glasgow.
- HM Government. (2008). Drugs: Protecting families and changing communities. London: HM Government.
- Lanarkshire ADAT. (2003). Methadone client survey: Summary report. Lanarkshri Alcohol and Drug action Team: Coatbridge, UK.
- Lanarkshire ADAT. (2007). Lanarkshire Drug Related Deaths 2002–2007: A report by the Lanarkshire ADAT Critical Incident Sub-Group. Lanarkshri Alcohol and Drug action Team: Coatbridge, UK.
- Lanarkshire ADAT. (2008). Substitute prescribing audit. Unpublished report.
- Magura, S. (2009). What more do we need to know about medication-assisted treatment for prescription opioid abusers? Addiction, 104, 784–785.
- Mattick, S., Kimber, J., Breen, C., & Davoli, M. (2008). Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence (review). The Cochrane Collaboration.
- Mintzer, M. Z., Copersino, M. L., & Stitzer, M. L. (2005). Opioid abuse and cognitive performance. Drug and Alcohol Dependence, 78, 225–230.
- National Institute of Health and Clinical Excellence. (2007). Methadone and buprenorphine for the management of opioid dependence. NICE technology appraisal guidance 114. London: NICE.
- Pinto, H., Rumball, D., & Holland, R. (2008). Attitudes and knowledge of substance misusers regarding buprenorphine and methadone maintenance therapy. Journal of Substance Use, 13, 143–153.
- Rapeli, P., Fabritius, C., Alho, H., Salaspuro, M., Wahlbeck, K., & Kalska, H. (2007). Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls. BMC Clinical Pharmacology, 7, 1–10.
- Scottish Government. (2008). The road to recovery: A new approach to tackling Scotland's drug problem. Edinburgh: Scottish Government.